Literature DB >> 15462253

Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic.

Mahnaz Sarrafizadeh1, Nancy M Waite, Eric H Hobson, Hedy Migden.   

Abstract

PURPOSE: Efforts to reduce patients' out-of-pocket expenses for prescription drugs by incorporating pharmaceutical manufacturer assistance programs (PMAPs) into a private ambulatory care facility's pharmaceutical services are described.
SUMMARY: From March 2001 through March 2002, the clinic's pharmacist prospectively evaluated patients for PMAP enrollment. The pharmacist completed the pharmaceutical manufacturer's application forms for patients identified as candidates for PMAP assistance and helped them obtain documentation. Some companies sent medications directly to patients, and others sent them to the clinic, where they were stored until the patients picked them up. The patients informed the pharmacist when refills were needed, which allowed the pharmacist to review patient records, verify compliance, and ensure proper follow-up. Forty-four patients were enrolled in 22 PMAPs during the year. The mean +/- S.D. annual household income for all patients was 15,631 dollars +/- 7,845 dollars. A total of 115 medication orders were processed for the patients. The mean +/- S.D. number of medications per patient obtained through PMAPs was 2.5 +/- 1.8, and the mean +/- S.D. number of refills was 1.8 +/- 1.0. The total cost of the medications was 48,143 dollars. The pharmacist needed an average of 15-20 minutes to perform the initial patient interview, 10-15 minutes to complete each initial application, and 5-15 minutes to complete a renewal application. Total pharmacist time needed to process each medication order was estimated at about one hour per year.
CONCLUSION: A pharmacist in a private ambulatory care facility helped patients enroll in PMAPs and reduced the patients' expenses for prescription drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15462253     DOI: 10.1093/ajhp/61.17.1816

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  8 in total

1.  A copay foundation assistance support program for patients receiving intravenous cancer therapy.

Authors:  Swapnil P Rajurkar; Cary A Presant; Linda D Bosserman; Wendy J McNatt
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

2.  Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan.

Authors:  Salah M AbuRuz; Yazan Alrashdan; Anan Jarab; Deema Jaber; Izzat A Alawwa
Journal:  Int J Clin Pharm       Date:  2013-07-25

3.  Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.

Authors:  Limin Gao; Jivin Joseph; Marcelle Santoro-Levy; Alan S Multz; Vladimir K Gotlieb
Journal:  Hosp Pharm       Date:  2016-07

4.  Medication assistance programs: do all in need benefit equally?

Authors:  Maria Pisu; Katie Crenshaw; Ellen Funkhouser; Midge Ray; Catarina I Kiefe; Kenneth Saag; Cynthia LaCivita; Jeroan J Allison
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

5.  Cost savings analysis of prescription assistance programs at a student-run free clinic.

Authors:  Nathan Chow; Annie Snitman; John Rafael; Stephanie Bui; Kelly Bennett; Fiona Prabhu
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-01-18

6.  Drug company-sponsored patient assistance programs: a viable safety net?

Authors:  Niteesh K Choudhry; Joy L Lee; Jessica Agnew-Blais; Colleen Corcoran; William H Shrank
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

7.  Patient Assistance Programs and Technology in Medication Adherence.

Authors:  Carlos Colon; Paulette Salas; Militza Díaz; Raiza Cotto; Isabel Martínez; Genevieve M Hale; Nile M Khanfar
Journal:  Innov Pharm       Date:  2020-04-30

8.  Serving underserved transplant recipients: experience of the Medication Access Program.

Authors:  Christina A Spivey; Marie A Chisholm-Burns; Charlene Garrett; Kenneth M Duke
Journal:  Patient Prefer Adherence       Date:  2014-05-02       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.